Barriers to Black Women's Participation in Cancer Clinical Trials

Charles Mouton, Sonja Harris, Susan Rovi, Patty Solorzano, Mark S. Johnson

Research output: Contribution to journalArticle

126 Citations (Scopus)

Abstract

This study examines attitudes that may deter black women from participating in cancer research. Subjects were recruited from women who did not respond to the initial recruitment mailing for the Women's Health Initiative. Each subject was administered a 7- to 10-minute telephone survey. One third (29) of the 80 subjects were black. Fifty-six percent of black women and 71% of white women had positive attitudes toward cancer clinical trials. More than 80% of the women surveyed agreed that clinical research benefits society and increases medical knowledge. However, almost one third of the black women agreed that scientists cannot be trusted while only 4% of whites responded similarly. Additionally, 29% of black women agreed that researchers did not care about them compared with 14% of white women. Only 28% of black women felt that clinical research in the United States was ethical, and 37% had a preference to be treated by a black scientist compared with 2% of whites. Controlling for other covariates, black women had more negative attitudes overall to clinical trials than white women. These findings support the likelihood that barriers exist for the participation of blacks and other minorities in clinical research. These barriers may impact the involvement of black women in cancer clinical trials. Improving trust and creating a perception of a caring attitude from investigators are important to overcoming these barriers. The inclusion of more black scientists as leaders of cancer clinical trials also may help improve these participation rates.

Original languageEnglish (US)
Pages (from-to)721-727
Number of pages7
JournalJournal of the National Medical Association
Volume89
Issue number11
StatePublished - Nov 1997
Externally publishedYes

Fingerprint

Clinical Trials
Neoplasms
Research
Research Personnel
Medical Societies
Women's Health
Telephone

Keywords

  • Blacks
  • Clinical trials
  • Recruitment

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Mouton, C., Harris, S., Rovi, S., Solorzano, P., & Johnson, M. S. (1997). Barriers to Black Women's Participation in Cancer Clinical Trials. Journal of the National Medical Association, 89(11), 721-727.

Barriers to Black Women's Participation in Cancer Clinical Trials. / Mouton, Charles; Harris, Sonja; Rovi, Susan; Solorzano, Patty; Johnson, Mark S.

In: Journal of the National Medical Association, Vol. 89, No. 11, 11.1997, p. 721-727.

Research output: Contribution to journalArticle

Mouton, C, Harris, S, Rovi, S, Solorzano, P & Johnson, MS 1997, 'Barriers to Black Women's Participation in Cancer Clinical Trials', Journal of the National Medical Association, vol. 89, no. 11, pp. 721-727.
Mouton, Charles ; Harris, Sonja ; Rovi, Susan ; Solorzano, Patty ; Johnson, Mark S. / Barriers to Black Women's Participation in Cancer Clinical Trials. In: Journal of the National Medical Association. 1997 ; Vol. 89, No. 11. pp. 721-727.
@article{9ffa60a6054e40529f18b9a448182be9,
title = "Barriers to Black Women's Participation in Cancer Clinical Trials",
abstract = "This study examines attitudes that may deter black women from participating in cancer research. Subjects were recruited from women who did not respond to the initial recruitment mailing for the Women's Health Initiative. Each subject was administered a 7- to 10-minute telephone survey. One third (29) of the 80 subjects were black. Fifty-six percent of black women and 71{\%} of white women had positive attitudes toward cancer clinical trials. More than 80{\%} of the women surveyed agreed that clinical research benefits society and increases medical knowledge. However, almost one third of the black women agreed that scientists cannot be trusted while only 4{\%} of whites responded similarly. Additionally, 29{\%} of black women agreed that researchers did not care about them compared with 14{\%} of white women. Only 28{\%} of black women felt that clinical research in the United States was ethical, and 37{\%} had a preference to be treated by a black scientist compared with 2{\%} of whites. Controlling for other covariates, black women had more negative attitudes overall to clinical trials than white women. These findings support the likelihood that barriers exist for the participation of blacks and other minorities in clinical research. These barriers may impact the involvement of black women in cancer clinical trials. Improving trust and creating a perception of a caring attitude from investigators are important to overcoming these barriers. The inclusion of more black scientists as leaders of cancer clinical trials also may help improve these participation rates.",
keywords = "Blacks, Clinical trials, Recruitment",
author = "Charles Mouton and Sonja Harris and Susan Rovi and Patty Solorzano and Johnson, {Mark S.}",
year = "1997",
month = "11",
language = "English (US)",
volume = "89",
pages = "721--727",
journal = "Journal of the National Medical Association",
issn = "1943-4693",
publisher = "National Medical Association",
number = "11",

}

TY - JOUR

T1 - Barriers to Black Women's Participation in Cancer Clinical Trials

AU - Mouton, Charles

AU - Harris, Sonja

AU - Rovi, Susan

AU - Solorzano, Patty

AU - Johnson, Mark S.

PY - 1997/11

Y1 - 1997/11

N2 - This study examines attitudes that may deter black women from participating in cancer research. Subjects were recruited from women who did not respond to the initial recruitment mailing for the Women's Health Initiative. Each subject was administered a 7- to 10-minute telephone survey. One third (29) of the 80 subjects were black. Fifty-six percent of black women and 71% of white women had positive attitudes toward cancer clinical trials. More than 80% of the women surveyed agreed that clinical research benefits society and increases medical knowledge. However, almost one third of the black women agreed that scientists cannot be trusted while only 4% of whites responded similarly. Additionally, 29% of black women agreed that researchers did not care about them compared with 14% of white women. Only 28% of black women felt that clinical research in the United States was ethical, and 37% had a preference to be treated by a black scientist compared with 2% of whites. Controlling for other covariates, black women had more negative attitudes overall to clinical trials than white women. These findings support the likelihood that barriers exist for the participation of blacks and other minorities in clinical research. These barriers may impact the involvement of black women in cancer clinical trials. Improving trust and creating a perception of a caring attitude from investigators are important to overcoming these barriers. The inclusion of more black scientists as leaders of cancer clinical trials also may help improve these participation rates.

AB - This study examines attitudes that may deter black women from participating in cancer research. Subjects were recruited from women who did not respond to the initial recruitment mailing for the Women's Health Initiative. Each subject was administered a 7- to 10-minute telephone survey. One third (29) of the 80 subjects were black. Fifty-six percent of black women and 71% of white women had positive attitudes toward cancer clinical trials. More than 80% of the women surveyed agreed that clinical research benefits society and increases medical knowledge. However, almost one third of the black women agreed that scientists cannot be trusted while only 4% of whites responded similarly. Additionally, 29% of black women agreed that researchers did not care about them compared with 14% of white women. Only 28% of black women felt that clinical research in the United States was ethical, and 37% had a preference to be treated by a black scientist compared with 2% of whites. Controlling for other covariates, black women had more negative attitudes overall to clinical trials than white women. These findings support the likelihood that barriers exist for the participation of blacks and other minorities in clinical research. These barriers may impact the involvement of black women in cancer clinical trials. Improving trust and creating a perception of a caring attitude from investigators are important to overcoming these barriers. The inclusion of more black scientists as leaders of cancer clinical trials also may help improve these participation rates.

KW - Blacks

KW - Clinical trials

KW - Recruitment

UR - http://www.scopus.com/inward/record.url?scp=0031262389&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031262389&partnerID=8YFLogxK

M3 - Article

C2 - 9375475

AN - SCOPUS:0031262389

VL - 89

SP - 721

EP - 727

JO - Journal of the National Medical Association

JF - Journal of the National Medical Association

SN - 1943-4693

IS - 11

ER -